DE69837600D1 - Aus einer menschlichen glial zelllinie-abgeleiteter promotor eines neurotrophischen faktors, diesen enthaltende vektoren und methoden zum screenen von verbindungen damit - Google Patents

Aus einer menschlichen glial zelllinie-abgeleiteter promotor eines neurotrophischen faktors, diesen enthaltende vektoren und methoden zum screenen von verbindungen damit

Info

Publication number
DE69837600D1
DE69837600D1 DE69837600T DE69837600T DE69837600D1 DE 69837600 D1 DE69837600 D1 DE 69837600D1 DE 69837600 T DE69837600 T DE 69837600T DE 69837600 T DE69837600 T DE 69837600T DE 69837600 D1 DE69837600 D1 DE 69837600D1
Authority
DE
Germany
Prior art keywords
cell line
neurotrophic factor
screening compounds
glial cell
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69837600T
Other languages
English (en)
Other versions
DE69837600T2 (de
Inventor
Preston Albert Baecker
Randolph Mellus Johnson
Walter Hom Lee
Adrian Neil Verity
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of DE69837600D1 publication Critical patent/DE69837600D1/de
Publication of DE69837600T2 publication Critical patent/DE69837600T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/44—Vectors comprising a special translation-regulating system being a specific part of the splice mechanism, e.g. donor, acceptor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DE69837600T 1997-08-05 1998-07-23 Aus einer menschlichen glial zelllinie-abgeleiteter promotor eines neurotrophischen faktors, diesen enthaltende vektoren und methoden zum screenen von verbindungen damit Expired - Fee Related DE69837600T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US5481297P 1997-08-05 1997-08-05
US54812P 1997-08-05
US8175198P 1998-04-14 1998-04-14
US81751P 1998-04-14
PCT/EP1998/004620 WO1999007843A1 (en) 1997-08-05 1998-07-23 Human glial cell line-derived neurotrophic factor promoters, vectors containing same, and methods of screening compounds therewith

Publications (2)

Publication Number Publication Date
DE69837600D1 true DE69837600D1 (de) 2007-05-31
DE69837600T2 DE69837600T2 (de) 2007-12-27

Family

ID=26733548

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69837600T Expired - Fee Related DE69837600T2 (de) 1997-08-05 1998-07-23 Aus einer menschlichen glial zelllinie-abgeleiteter promotor eines neurotrophischen faktors, diesen enthaltende vektoren und methoden zum screenen von verbindungen damit

Country Status (7)

Country Link
EP (1) EP1002071B1 (de)
JP (1) JP3761152B2 (de)
AT (1) ATE360066T1 (de)
AU (1) AU737944B2 (de)
CA (1) CA2299586C (de)
DE (1) DE69837600T2 (de)
WO (1) WO1999007843A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19816186A1 (de) * 1998-04-14 1999-10-21 Univ Muenchen L Maximilians GDNF-kodierende DNA, Teile davon und GDNF-Varianten
US20110003701A1 (en) * 2008-02-27 2011-01-06 454 Life Sciences Corporation System and method for improved processing of nucleic acids for production of sequencable libraries
EP2968462B1 (de) 2013-03-15 2020-12-23 The Jackson Laboratory Verfahren zur förderung von wundheilung und haarwachstum

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1243652A3 (de) * 1991-09-20 2003-03-26 Amgen Inc., Glial neurotropher Faktor
AU6975198A (en) * 1997-04-15 1998-11-11 University Of Medicine And Dentistry Of New Jersey Cdna for human gdnf and promoter therefor which allows regulated and constitutive expression

Also Published As

Publication number Publication date
DE69837600T2 (de) 2007-12-27
EP1002071B1 (de) 2007-04-18
EP1002071A1 (de) 2000-05-24
AU737944B2 (en) 2001-09-06
ATE360066T1 (de) 2007-05-15
JP3761152B2 (ja) 2006-03-29
CA2299586A1 (en) 1999-02-18
CA2299586C (en) 2007-09-18
JP2001512679A (ja) 2001-08-28
AU9067998A (en) 1999-03-01
WO1999007843A1 (en) 1999-02-18

Similar Documents

Publication Publication Date Title
DE69132725T2 (de) Neue sequenzen vorzugsweise exprimiert während der frühen keimentwicklung und darauf bezogene methoden
EP1502952A3 (de) Verfahren zur Herstellung von Proteinprodukten in Aspergillus-Oryzae und in Aspergillus zu verwendender Promotor
NO20093194L (no) Vektor for uttrykkelse av en sekvens som koder for et cytotoksisk genprodukt, og anvendelse av denne for a fremstille et medikament for behandling av cancer
PT852585E (pt) Metodo de tratamento da doenca de alzheimer utilizando um produto proteico de factor neurotrofico derivado de uma linha de celulas gliais.
EP0523140A4 (en) Reagents and methods for modulating gene expression through rna mimicry
DE59712538D1 (de) Verwendung von Pigmentpräparationen für den Ink-Jet Druck
NO833464L (no) Dna sekvenser, rekombinant dna molekyler og fremgangsmaater ved fremstilling av svinevekst hormonliknende polypeptider
DE3856319T2 (de) Regenerierung und transformation von baumwolle
HU9300397D0 (en) Method for modifying tropism of micor-organisms to cells, tissues and host organisms recombinant micro-organisms obtained by this way and their application in human and veterinary medicine
DE69837600D1 (de) Aus einer menschlichen glial zelllinie-abgeleiteter promotor eines neurotrophischen faktors, diesen enthaltende vektoren und methoden zum screenen von verbindungen damit
DE68919140D1 (de) Hühner-beta-Actin-Genpromoter enthaltender Vektor zur Expression eines erwünschten Gens.
NO924576D0 (no) Kloning og ekspresjon av gener som koder for arabinan-nedbrytende enzymer av sopp-opprinnelse
ATE233483T1 (de) Wässrige lösung zum konservieren von gewebe und organen
ATE280224T1 (de) Promotorelemente, welche wurzel-bevorzugte genexpression verleihen
WO1996040951A3 (en) Use of ovary-tissue transcriptional factors
JP2007535943A (ja) ３ＭＨｚ〜１２５ＭＨｚのパルス無線周波数を組み込む波形を用いるエレクトロポレーションによる細菌形質転換のための方法および装置
DE69424848D1 (de) Verfahren und Kit zum Färben der Haaren
JP2000004875A (ja) 増殖因子の産生誘導方法
DE69533905D1 (de) Interferon alpha/beta bindendes Protein, seine Herstellung und Anwendung
ATE184915T1 (de) Verfahren zur herstellung von vakzinen und ihre verwendung
NO975682L (no) Pyridiniminyl-1,2-benzisoxazoler og -benzisothiazoler som anti-psykotiske midler
DK82391D0 (da) Ekspression og bearbejdning i gaer af autentiske humane fibroblastvaekstfaktorer
WO2003064465A3 (en) Prkag3 gene promoter and uses thereof
DK1639110T3 (da) Rajgræspollenspecifikke promotorer og ekspressionskonstructer
CHRISTOFFERSEN ETHYLENE CONTROL OF GENE EXPRESSION IN FRUITS AND STORAGE ORGANS (PLANT, HORMONE, MESSENGER-RNA)

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee